← All trials
NCT06294262
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 29, 2024
- Primary completion
- Sep 30, 2024
- Completion date
- Mar 31, 2025
- First posted
- Mar 5, 2024
- Last posted
- Jul 29, 2024
- Enrollment
- 84
- Arms / groups
- 6 / —
- Source
- AACT · ctgov ingestion
Sponsors
- LiteVax BVLead sponsor
- Ghent UniversityCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.